Download presentation
Presentation is loading. Please wait.
Published byKerry Benson Modified over 9 years ago
1
A disease risk index for patients undergoing allogeneic stem cell transplantation by Philippe Armand, Christopher J. Gibson, Corey Cutler, Vincent T. Ho, John Koreth, Edwin P. Alyea, Jerome Ritz, Mohamed L. Sorror, Stephanie J. Lee, H. Joachim Deeg, Barry E. Storer, Frederick R. Appelbaum, Joseph H. Antin, Robert J. Soiffer, and Haesook T. Kim Blood Volume 120(4):905-913 July 26, 2012 ©2012 by American Society of Hematology
2
OS after HSCT stratified by disease/status group and conditioning intensity. Philippe Armand et al. Blood 2012;120:905-913 ©2012 by American Society of Hematology
3
Outcomes of HSCT stratified by overall disease/status risk group. Philippe Armand et al. Blood 2012;120:905-913 ©2012 by American Society of Hematology
4
Outcomes of patients in the validation cohort stratified by disease/status risk group. Philippe Armand et al. Blood 2012;120:905-913 ©2012 by American Society of Hematology
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.